Literature DB >> 14687029

Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.

Keiko Fujii1, Fumihiko Ishimaru, Teruhiko Kozuka, Keitaro Matsuo, Koichi Nakase, Itaru Kataoka, Takayuki Tabayashi, Katsuji Shinagawa, Kazuma Ikeda, Mine Harada, Mitsune Tanimoto.   

Abstract

We examined serum levels of the angiogenic factors, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and hepatocyte growth factor (HGF), in normal donors for allogeneic peripheral blood stem cell (PBSC) transplantation. Granulocyte colony-stimulating factor (G-CSF) (filgrastim 400 microg/m2/d) was administered to 23 donors for 5 d and aphereses were performed on days 4 and 5. Although bFGF remained at similar levels after G-CSF treatment, serum VEGF and HGF levels increased 1.5-fold (n = 13; P = 0.02) and 6.8-fold (n = 23; P < 0.0001) respectively. The serum HGF level before G-CSF administration on day 1 correlated inversely with mobilized CD34+ cell numbers. Time course kinetics of HGF showed that on the day after G-CSF administration (day 2), serum HGF levels increased to 3678 pg/ml. For auto PBSC mobilization with chemotherapy and G-CSF 200 microg/m2/d (n = 8), we observed similar HGF elevation, which appeared to be dose-dependent on the G-CSF administered.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687029     DOI: 10.1046/j.1365-2141.2003.04745.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

Review 1.  Novel therapy for myocardial infarction: can HGF/Met be beneficial?

Authors:  V Sala; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2011-02-17       Impact factor: 9.261

2.  Granulocyte colony-stimulating factor activating HIF-1alpha acts synergistically with erythropoietin to promote tissue plasticity.

Authors:  Shih-Ping Liu; Shin-Da Lee; Hsu-Tung Lee; Demeral David Liu; Hsiao-Jung Wang; Ren-Shyan Liu; Shinn-Zong Lin; Ching-Yuan Su; Hung Li; Woei-Cherng Shyu
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

3.  Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies.

Authors:  Giuseppina Bonanno; Annabella Procoli; Andrea Mariotti; Maria Corallo; Alessandro Perillo; Silvio Danese; Raimondo De Cristofaro; Giovanni Scambia; Sergio Rutella
Journal:  J Transl Med       Date:  2010-11-09       Impact factor: 5.531

4.  Relationship between the cAMP levels in leukocytes and the cytokine balance in patients surviving gram negative bacterial pneumonia.

Authors:  Tomio Matsumoto; Keisuke Hayamizu; Seiji Marubayashi; Kiyoshi Shimizu; Aki Hamamoto; Tsuyoshi Yamaguchi; Junji Hashizume; Takashi Onabe; Toshimasa Asahara; Hideki Ohdan
Journal:  J Clin Biochem Nutr       Date:  2011-02-26       Impact factor: 3.114

5.  G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration.

Authors:  K T Morris; H Khan; A Ahmad; L L Weston; R A Nofchissey; I V Pinchuk; E J Beswick
Journal:  Br J Cancer       Date:  2014-01-21       Impact factor: 7.640

6.  Increased FSHD region gene1 expression reduces in vitro cell migration, invasion, and angiogenesis, ex vivo supported by reduced expression in tumors.

Authors:  Ankit Tiwari; Niharika Pattnaik; Archita Mohanty Jaiswal; Manjusha Dixit
Journal:  Biosci Rep       Date:  2017-10-27       Impact factor: 3.840

7.  Filgrastim, fibrinolysis, and neovascularization.

Authors:  Darwin Eton; Guolin Zhou; Tong-Chuan He; Amelia Bartholomew; Rachana Patil
Journal:  J Tissue Eng Regen Med       Date:  2022-02-17       Impact factor: 4.323

Review 8.  Liver Regeneration by Hematopoietic Stem Cells: Have We Reached the End of the Road?

Authors:  Elena Konstantina Siapati; Maria G Roubelakis; George Vassilopoulos
Journal:  Cells       Date:  2022-07-27       Impact factor: 7.666

9.  Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial.

Authors:  Laurent Spahr; Yves Chalandon; Sylvain Terraz; Vincent Kindler; Laura Rubbia-Brandt; Jean-Louis Frossard; Romain Breguet; Nicolas Lanthier; Annarita Farina; Jakob Passweg; Christoph D Becker; Antoine Hadengue
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Neupogen and mesenchymal stem cells are the novel therapeutic agents in regeneration of induced endometrial fibrosis in experimental rats.

Authors:  Dina Sabry; Abeer Mostafa; Samar Marzouk; Walaa Ibrahim; Hanan H M Ali; Aymen Hassan; Ashraf Shamaa
Journal:  Biosci Rep       Date:  2017-10-11       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.